Quoted from http://news.yahoo.com/eu-medicines-agency-restrict-otsuka-drug-105637064--sector.html
EU medicines agency to restrict use of Otsuka drugReuters–Fri, Mar 22, 2013
LONDON (Reuters) - The European Medicines Agency said on Friday it was recommending restricting the use of medicines containing cilostazol, sold by Otsuka under the brand name Pletal, following concerns over side effects.
A review of evidence found the drug's modest benefit was only greater than its risk of damaging the heart or causing serious bleeding in a limited number of patients.
Cilostazol, also sold as Ekistol, is used for treatment of intermittent claudication, or limping, usually as a result of arterial disease.
[Article continues at original source]